ACH submitted additional comments to HRSA on the proposed 340B Rebate Model in April 2026. ACH encouraged HRSA to consider a neutral claims clearinghouse, operated by HHS, as an alternative option to the rebate model. In this scenario, covered entities would submit relevant claims data to the clearinghouse to prevent duplicate discounts and strengthen 340B […]
Shannon Young at 340B Report writes: “340B program stakeholders offered varying reactions following a late-December federal court ruling that halted the controversial rebate pilot from taking effect as planned, with providers celebrating the judge’s temporary pause, while the federal government and some drugmakers pushed back against the order.” Advocates for Community Health (ACH) spokesperson Sandy […]
